337 related articles for article (PubMed ID: 15743177)
21. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, molecular modeling, and biological studies of novel piperidine-based analogues of cocaine: evidence of unfavorable interactions proximal to the 3alpha-position of the piperidine ring.
Petukhov PA; Zhang J; Wang CZ; Ye YP; Johnson KM; Kozikowski AP
J Med Chem; 2004 Jun; 47(12):3009-18. PubMed ID: 15163183
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
[TBL] [Abstract][Full Text] [Related]
25. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
26. Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
Dutta AK; Coffey LL; Reith ME
J Med Chem; 1997 Jan; 40(1):35-43. PubMed ID: 9016326
[TBL] [Abstract][Full Text] [Related]
27. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter.
Zou MF; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2003 Jul; 46(14):2908-16. PubMed ID: 12825932
[TBL] [Abstract][Full Text] [Related]
29. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters.
Zhang S; Zhen J; Reith ME; Dutta AK
Bioorg Med Chem; 2004 Dec; 12(23):6301-15. PubMed ID: 15519172
[TBL] [Abstract][Full Text] [Related]
30. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
[TBL] [Abstract][Full Text] [Related]
32. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat.
Cook CD; Carroll IF; Beardsley PM
Psychopharmacology (Berl); 2001 Dec; 159(1):58-63. PubMed ID: 11797070
[TBL] [Abstract][Full Text] [Related]
33. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
34. The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor.
Grundt P; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem Lett; 2004 Jun; 14(12):3295-8. PubMed ID: 15149693
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters.
Carroll FI; Blough BE; Nie Z; Kuhar MJ; Howell LL; Navarro HA
J Med Chem; 2005 Apr; 48(8):2767-71. PubMed ID: 15828814
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter.
Dutta AK; Reith ME; Madras BK
Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
Simoni D; Rossi M; Bertolasi V; Roberti M; Pizzirani D; Rondanin R; Baruchello R; Invidiata FP; Tolomeo M; Grimaudo S; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
J Med Chem; 2005 May; 48(9):3337-43. PubMed ID: 15857139
[TBL] [Abstract][Full Text] [Related]
38. Role of the dopamine transporter and the sodium channel in the cocaine-like discriminative stimulus effects of local anesthetics in rats.
Wilcox KM; Paul IA; Ordway GA; Woolverton WL
Psychopharmacology (Berl); 2001 Sep; 157(3):260-8. PubMed ID: 11605081
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
40. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
